Poland· PL-100215418
Provive
A propofol product containing propofolum, registered in Poland by Baxter Holding B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Propofol is registered in 17 of 19 countries.
Countries holding a registration under ATC N01AX10 (propofol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Propofol · ATC N01AX10
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Propofolum
- Manufacturer
- Baxter Holding B.V.
- Country
- Poland (PL)
- ATC code
- N01AX10
- ATC class
- Propofol
- Defined daily dose
- 0.14 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 10
- gtin05909990727438
- gtin05909990727445
- gtin05909990727452
- gtin05909990727469
- gtin08902344341226
- gtin08902344341264
- gtin08907730003023
- gtin18907730002764
- gtin08907730002767
- gtin08907730007441
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for propofol.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Propofol · interactions on record
335 records
- 5 severe
- 177 moderate
- 6 minor
- 139 info
Most severe, free to view
- PapaverineA03AD01severe
- PapaverinC04AX38severe
- PapaverineG04BE02severe
- OzanimodL04AA38severe
8 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Propofol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDiprivanFresenius Kabi USA, LLC
- CzechiaANESIABaxter Holding B.V., Utrecht
- FinlandCurtegaPfizer Oy
- SwitzerlandDisoprivan 10 mg/ml, Emulsion zur Injektion/InfusionAspen Pharma Schweiz GmbH
- BelgiumPropofol B. Braun 1 % 10 mg/mlB. Braun Melsungen
- SpainDIPRIVAN 10 mg/ml EMULSION INYECTABLE Y PARA PERFUSIONAspen Pharma Trading Limited
- IrelandPropofol 1 % (10 mg/1 ml) Fresenius emulsion for injection or infusion, ampouleFresenius Kabi Deutschland GmbH
- SwedenProfast 10 mg/ml Injektionsvätska/infusionsvätska, emulsionBaxter Holding B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Propofol Mct Baxter, Propofol Mit Mct Fresenius
- Belgium · Diprivan, Diprivan 1%
- Bulgaria · Propofol Mct/Lct Fresenius, Пропофол Пф
- Cyprus · Hiremon, Propofol Mct/Lct Fresenius
- Czechia · Anesia Baxter, Propofol Baxter
- Germany · Disoprivan, Propofol Baxter
- Denmark · Profast, Profast Baxter
- Estonia · Anesia, Propofol-Lipuro B. Braun Melsungen
- Spain · Diprivan, Propofol Baxter
- Finland · Profast, Propofol-Lipuro B. Braun Melsungen
- France · Diprivan, Propofol Baxter
- United Kingdom (Northern Ireland) · Propofol, Propofol Aspen
- Greece · Hiremon, Propofol Baxter
- Croatia · Propofol Mct Fresenius, Propofol-Lipuro B. Braun Adria
- Hungary · Anesia, Propofol Mct Fresenius
- Ireland · Diprivan, Propofol
- Iceland · Propolipid
- Italy · Diprivan, Propofol B. Braun
- Lithuania · Anesia, Propofol-Lipuro B. Braun Melsungen
- Luxembourg · Diprivan, Diprivan 1%
- Latvia · Anesia, Propofol-Lipuro B. Braun Melsungen
- Malta · Propofol, Propofol Baxter Holding
- Netherlands · Diprivan-10, Diprivan-20
- Norway · Profast, Propofol-Lipuro B. Braun Melsungen
- Portugal · Propofol Baxter, Propofol Demo
- Romania · Profast, Propofol Mct/Lct Fresenius
- Sweden · Diprivan, Profast
- Slovenia · Anesia, Propofol Baxter
- Slovakia · Propofol Mct Fresenius, Propofol Mct/Lct Fresenius
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5be75de-1744-44dd-b808-e5eb2e558f8c GET /v1/drugs/f5be75de-1744-44dd-b808-e5eb2e558f8c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Emulsja do wstrzykiwań / do infuzji",
"source": "urpl",
"strength": "10 mg/ml",
"packaging": "05909990727438 ¦ Lz ¦ 52911\n1 fiol. 10 ml\n05909990727445 ¦ Lz ¦ 52912\n1 fiol. 20 ml\n05909990727452 ¦ Lz ¦ 52913\n1 fiol. 50 ml\n05909990727469 ¦ Lz ¦ 52914\n1 fiol. 100 ml\n08902344341226 ¦ Lz ¦ Skasowane ¦ 111030\n5 fiol. 20 ml\n08902344341264 ¦ Lz ¦ Skasowane ¦ 111031\n10 fiol. 20 ml\n08907730003023 ¦ Lz ¦ 132887\n5 fiol. 20 ml\n¦ UR/Z/4c/030/24 - 18907730002764 ¦ UR/Z/4c/003/24 - 08907730002767\n08907730007441 ¦ Lz ¦ 132888\n10 fiol. 20 ml",
"substance": "Propofolum 10 mg/ml",
"common_name": "Propofolum",
"pl_product_id": "100215418",
"pozwolenie_nr": "15862",
"auth_procedure": "MRP",
"authorisation_validity": "2026-01-13"
}See everything about propofol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.